At minimum: IGF-1 every 4 weeks, fasting glucose and insulin every 2 weeks initially (monthly once stable), HbA1c every 6 weeks, liver enzymes monthly, and comprehensive metabolic panel quarterly
These results showcase the ability of semaglutide to be a treatment option for cardiovascular benefit, notwithstanding the glycemic index
its not common, but its worth watching for
Connect with Kerry Traugott, DNP, and begin a personalized medical weight loss program designed to help you reach your goals safely and effectively
In short, how you lose weight matters just as much as how much you lose
[DOI] [PMC free article] [PubMed] [Google Scholar] 45.American Diabetes Association Professional Practice Committee